This means that patients can achieve their weight loss goals without experiencing the unwanted effects often associated with hormone-based therapies
Wilding et al., New England Journal of Medicine (2021) GLP-1 stimulates insulin release when blood sugar is elevated and suppresses glucagon, the hormone that raises it
Of this subset, the total mass loss was nearly 14 kg and while nearly 8.5 kg (about 60%) was fat loss, the 5 kg lean mass loss reported was 38%, which is on the high end of what wed expect, he told Healthline
While side effects are possible, they are often manageable with appropriate screening, education, monitoring, and individualized dosage guidance
Fake and counterfeit GLP-1s have hit the market
Zepbound (tirzepatide) is a prescription medication approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition